Nifekalant hydrochloride for patients with cardiac arrest caused by shockable rhythm

Circ J. 2010 Nov;74(11):2285-7. doi: 10.1253/circj.cj-10-0936. Epub 2010 Oct 16.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Arrhythmia Agents / administration & dosage*
  • Defibrillators
  • Electric Countershock* / instrumentation
  • Humans
  • Out-of-Hospital Cardiac Arrest / drug therapy
  • Out-of-Hospital Cardiac Arrest / etiology
  • Out-of-Hospital Cardiac Arrest / mortality
  • Out-of-Hospital Cardiac Arrest / therapy*
  • Patient Admission
  • Pyrimidinones / administration & dosage*
  • Survival Rate
  • Tachycardia, Ventricular / complications
  • Tachycardia, Ventricular / drug therapy
  • Tachycardia, Ventricular / mortality
  • Tachycardia, Ventricular / therapy*
  • Time Factors
  • Torsades de Pointes / chemically induced
  • Treatment Failure
  • Ventricular Fibrillation / complications
  • Ventricular Fibrillation / drug therapy
  • Ventricular Fibrillation / mortality
  • Ventricular Fibrillation / therapy*

Substances

  • Anti-Arrhythmia Agents
  • Pyrimidinones
  • nifekalant